The invention provides a mirtron capable of reducing the expression of the LRRK2 gene in a mammalian cell, the sequence of the mirtron comprising: (i) a 5' splice site; (ii) a 3' splice site; (iii) a branch-point recognition sequence; (iv) a 3' polypyrimidine tract greater than 15 nucleotides in length; and (v) an antisense sequence that is at least partially complementary to a sequence in the LRRK2 mRNA, or a gene capable of expressing said mirtron.
申请公布号
WO2011114106(A3)
申请公布日期
2012.01.05
申请号
WO2011GB00378
申请日期
2011.03.17
申请人
ISIS INNOVATION LIMITED;WOOD, MATTHEW;SIBLEY, CHRISTOPHER